" class="no-js "lang="en-US"> News Archives - Page 165 of 267 - Medtech Alert
Thursday, June 18, 2026

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

FDA Approves Roche’s Vabysmo, the First Bispecific Antibody for the Eye, to Treat Two Leading Causes of Vision Loss

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration […]

IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology

IAVI, the nonprofit scientific research organization, and biotechnology company Moderna announced today that first doses […]

Dr. Blackford Middleton Joins ClosedLoop to Improve Clinical Decisions With AI

ClosedLoop, healthcare’s data science platform, today announced that renowned clinical informatics expert Dr. Blackford Middleton […]

Epic Sciences and Biosplice Therapeutics Announce Partnership for Metastatic Cancer Trials

Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for […]

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate

HaemaLogiX Ltd (HaemaLogiX), the clinical-stage biotechnology company developing novel monoclonal antibody therapies for multiple myeloma, […]

Samsung Biologics Reaches Agreement with Biogen to Acquire Full Ownership of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has reached an agreement with Biogen for the buyout […]

Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing

Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]

SBRI Healthcare Awards £1 Million to Pioneering Innovations to Support the Delivery of a Net Zero NHS

SBRI Healthcare has awarded a total of £1 million to ten pioneering MedTech and Digital […]

Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments

Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more